AU2001280471A1 - Novel secreted proteins and their uses - Google Patents
Novel secreted proteins and their usesInfo
- Publication number
- AU2001280471A1 AU2001280471A1 AU2001280471A AU8047101A AU2001280471A1 AU 2001280471 A1 AU2001280471 A1 AU 2001280471A1 AU 2001280471 A AU2001280471 A AU 2001280471A AU 8047101 A AU8047101 A AU 8047101A AU 2001280471 A1 AU2001280471 A1 AU 2001280471A1
- Authority
- AU
- Australia
- Prior art keywords
- secreted proteins
- novel secreted
- novel
- proteins
- secreted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US22464200P | 2000-08-11 | 2000-08-11 | |
US60/224,642 | 2000-08-11 | ||
US24177900P | 2000-10-19 | 2000-10-19 | |
US60/241,779 | 2000-10-19 | ||
PCT/US2001/021124 WO2002014358A2 (en) | 2000-08-11 | 2001-07-30 | Novel secreted proteins and their uses |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001280471A1 true AU2001280471A1 (en) | 2002-02-25 |
Family
ID=26918895
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001280471A Abandoned AU2001280471A1 (en) | 2000-08-11 | 2001-07-30 | Novel secreted proteins and their uses |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP1309614A2 (en) |
AU (1) | AU2001280471A1 (en) |
WO (1) | WO2002014358A2 (en) |
Families Citing this family (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030149238A1 (en) * | 2000-02-14 | 2003-08-07 | Pankaj Agarwal | Novel compounds |
AU2002217838A1 (en) | 2000-11-14 | 2002-05-27 | Bristol-Myers Squibb Company | A human serpin secreted from lymphoid cells LSI-01 |
JP2007063225A (en) | 2005-09-01 | 2007-03-15 | Takeda Chem Ind Ltd | Imidazopyridine compound |
JP5302012B2 (en) | 2006-03-08 | 2013-10-02 | タケダ カリフォルニア インコーポレイテッド | Glucokinase activator |
EP2049518B1 (en) | 2006-05-31 | 2011-08-31 | Takeda San Diego, Inc. | Indazole and isoindole derivatives as glucokinase activating agents. |
US7572618B2 (en) | 2006-06-30 | 2009-08-11 | Bristol-Myers Squibb Company | Polynucleotides encoding novel PCSK9 variants |
CA2669424A1 (en) | 2006-11-07 | 2008-05-29 | Merck & Co., Inc. | Antagonists of pcsk9 |
EP2091947A2 (en) | 2006-12-20 | 2009-08-26 | Takeda San Diego, Inc. | Glucokinase activators |
US8173645B2 (en) | 2007-03-21 | 2012-05-08 | Takeda San Diego, Inc. | Glucokinase activators |
US8263353B2 (en) | 2007-03-27 | 2012-09-11 | Merck Sharp & Dohme Corp. | Method for detecting autoprocessed, secreted PCSK9 |
JOP20080381B1 (en) | 2007-08-23 | 2023-03-28 | Amgen Inc | Antigen Binding Proteins to Proprotein Convertase subtillisin Kexin type 9 (pcsk9) |
AR070315A1 (en) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | ANTIBODIES 1B20 ANTAGONISTS OF PCSK9 |
AR070316A1 (en) | 2008-02-07 | 2010-03-31 | Merck & Co Inc | PCSK9 ANTAGONISTS (SUBTILISINE-KEXINA TYPE 9 PROPROTEIN) |
US8748115B2 (en) | 2008-12-12 | 2014-06-10 | Merck Sharp & Dohme Corp. | PCSK9 immunoassay |
WO2011053759A1 (en) | 2009-10-30 | 2011-05-05 | Merck Sharp & Dohme Corp. | Ax1 and ax189 pcsk9 antagonists and variants |
WO2011053783A2 (en) | 2009-10-30 | 2011-05-05 | Merck Sharp & Dohme Corp. | Ax213 and ax132 pcsk9 antagonists and variants |
HUE056313T2 (en) | 2010-01-29 | 2022-02-28 | Chugai Pharmaceutical Co Ltd | Anti-dll3 antibody |
AR087715A1 (en) | 2011-09-16 | 2014-04-09 | Lilly Co Eli | ANTI PCSK9 ANTIBODIES AND USES OF THE SAME |
WO2013126746A2 (en) | 2012-02-24 | 2013-08-29 | Stem Centrx, Inc. | Novel modulators and methods of use |
BR112014031310A2 (en) | 2012-06-15 | 2017-07-25 | Genentech Inc | anti-pcsk9 antibodies, formulations, dosage and methods of use |
CN105164159A (en) | 2013-02-22 | 2015-12-16 | 施特姆森特克斯股份有限公司 | Novel antibody conjugates and uses thereof |
CN105848671B (en) | 2013-08-28 | 2019-12-13 | 艾伯维施特姆森特克斯有限责任公司 | Site-specific antibody conjugation methods and compositions |
US9023359B1 (en) | 2014-07-15 | 2015-05-05 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US8980273B1 (en) | 2014-07-15 | 2015-03-17 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US9045545B1 (en) | 2014-07-15 | 2015-06-02 | Kymab Limited | Precision medicine by targeting PD-L1 variants for treatment of cancer |
US9034332B1 (en) | 2014-07-15 | 2015-05-19 | Kymab Limited | Precision medicine by targeting rare human PCSK9 variants for cholesterol treatment |
US8945560B1 (en) | 2014-07-15 | 2015-02-03 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
US8986691B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Method of treating atopic dermatitis or asthma using antibody to IL4RA |
US8986694B1 (en) | 2014-07-15 | 2015-03-24 | Kymab Limited | Targeting human nav1.7 variants for treatment of pain |
US9017678B1 (en) | 2014-07-15 | 2015-04-28 | Kymab Limited | Method of treating rheumatoid arthritis using antibody to IL6R |
US9067998B1 (en) | 2014-07-15 | 2015-06-30 | Kymab Limited | Targeting PD-1 variants for treatment of cancer |
US8883157B1 (en) | 2013-12-17 | 2014-11-11 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US8992927B1 (en) | 2014-07-15 | 2015-03-31 | Kymab Limited | Targeting human NAV1.7 variants for treatment of pain |
US9051378B1 (en) | 2014-07-15 | 2015-06-09 | Kymab Limited | Targeting rare human PCSK9 variants for cholesterol treatment |
US9914769B2 (en) | 2014-07-15 | 2018-03-13 | Kymab Limited | Precision medicine for cholesterol treatment |
US9045548B1 (en) | 2014-07-15 | 2015-06-02 | Kymab Limited | Precision Medicine by targeting rare human PCSK9 variants for cholesterol treatment |
MX2016010677A (en) | 2014-02-21 | 2017-04-10 | Abbvie Stemcentrx Llc | Anti-dll3 antibodies and drug conjugates for use in melanoma. |
GB201403775D0 (en) | 2014-03-04 | 2014-04-16 | Kymab Ltd | Antibodies, uses & methods |
US9139648B1 (en) | 2014-07-15 | 2015-09-22 | Kymab Limited | Precision medicine by targeting human NAV1.9 variants for treatment of pain |
US9150660B1 (en) | 2014-07-15 | 2015-10-06 | Kymab Limited | Precision Medicine by targeting human NAV1.8 variants for treatment of pain |
EP3534947A1 (en) | 2016-11-03 | 2019-09-11 | Kymab Limited | Antibodies, combinations comprising antibodies, biomarkers, uses & methods |
GB2572918B (en) | 2016-12-23 | 2023-02-15 | Harvard College | Gene editing of PCSK9 |
US11667713B2 (en) | 2017-12-28 | 2023-06-06 | Chugai Seiyaku Kabushiki Kaisha | Cytotoxicity-inducing therapeutic agent |
CN115397866A (en) | 2020-03-31 | 2022-11-25 | 中外制药株式会社 | DLL 3-targeted multispecific antigen-binding molecules and uses thereof |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5916751A (en) * | 1996-08-27 | 1999-06-29 | University Of South Florida | Method for the diagnosis of selected adenocarcinomas |
AU8580098A (en) * | 1997-07-31 | 1999-02-22 | Johns Hopkins University School Of Medicine, The | Growth differentiation factor, lefty-2 |
WO1999009198A1 (en) * | 1997-08-21 | 1999-02-25 | Human Genome Sciences, Inc. | Human nodal and lefty homologues |
US6027917A (en) * | 1997-12-10 | 2000-02-22 | Genetics Institute, Inc. | Bone morphogenetic protein (BMP)-17 and BMP-18 compositions |
US6747004B1 (en) * | 1999-04-29 | 2004-06-08 | North Shore - Long Island Jewish Research Institute | Method for inducing growth and enhancing survival of nervous tissue |
-
2001
- 2001-07-30 AU AU2001280471A patent/AU2001280471A1/en not_active Abandoned
- 2001-07-30 WO PCT/US2001/021124 patent/WO2002014358A2/en not_active Application Discontinuation
- 2001-07-30 EP EP01958861A patent/EP1309614A2/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002014358A2 (en) | 2002-02-21 |
EP1309614A2 (en) | 2003-05-14 |
WO2002014358A3 (en) | 2003-03-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001280471A1 (en) | Novel secreted proteins and their uses | |
AU7602400A (en) | Secreted proteins and uses thereof | |
AU2001271683A1 (en) | Novel secreted proteins | |
AU2001237958A1 (en) | 22 human secreted proteins | |
AU2002233994A1 (en) | Secreted proteins | |
AU2001227833A1 (en) | 71 human secreted proteins | |
AU2001270045A1 (en) | Secreted proteins | |
AU2002232596A1 (en) | Secreted human proteins | |
AU6394400A (en) | Secreted proteins and uses thereof | |
AU2001255320A1 (en) | Secreted proteins | |
AU2001237957A1 (en) | 17 human secreted proteins | |
AU2001245308A1 (en) | 207 human secreted proteins | |
AU2396600A (en) | Secreted proteins and uses thereof | |
AU2002211220A1 (en) | Secreted proteins and their uses | |
AU5750200A (en) | Secreted proteins and uses thereof | |
AU2001290551A1 (en) | Secreted proteins and their uses | |
AU2002236440A1 (en) | Novel secreted proteins and their uses | |
AU2001294719A1 (en) | Secreted human proteins | |
AU3382800A (en) | Secreted proteins and uses thereof | |
AU1190801A (en) | Secreted proteins and uses thereof | |
WO2000069885A8 (en) | Secreted proteins and uses thereof | |
AU2001229366A1 (en) | Secreted proteins | |
AU2001229507A1 (en) | 21 human secreted proteins | |
AU2001283327A1 (en) | 8 human secreted proteins | |
AU2001255668A1 (en) | 29 human secreted proteins |